Open AccessPD32-02 NOVEL PI3K/P110BETA-SPECIFIC INHIBITORS ELIMINATE ENZALUTAMIDE RESISTANCE IN PROSTATE CANCER
Author(s) -
Marcus Austenfeld,
Chenchen He,
YiFen Wang,
Qingting Hu,
Brantley Thrasher,
Benyi Li
Publication year - 2016
Publication title -
the journal of urology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2016.02.678
Subject(s) - enzalutamide , prostate cancer , medicine , transactivation , cancer research , cancer , androgen receptor , pi3k/akt/mtor pathway , cancer cell , oncology , signal transduction , biology , biochemistry , transcription factor , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom